The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Clinical Implications of Basic Research
PreviousPrevious
Volume 350:2093-2094 May 13, 2004 Number 20
NextNext

The Molecular Basis of Streptococcal Toxic Shock Syndrome
Eric J. Brown, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
Streptococcus pyogenes, also known as group A streptococcus, is the cause of purulent pharyngitis and pyoderma, occasionally complicated by scarlet fever, rheumatic fever, and glomerulonephritis — a scenario familiar to every medical student. Less frequently, group A streptococcus causes deep-tissue infection, bacteremia, and sepsis with vascular collapse and organ failure, a syndrome known as the streptococcal toxic shock syndrome. M protein, a constituent of the streptococcal cell wall, has been known for half a century to be a virulence factor of group A streptococcus, both because it induces a host immune response that contributes to the immunologic complications of streptococcal . . . [Full Text of this Article]


Source Information

From the Program in Microbial Pathogenesis and Host Defense, University of California at San Francisco, San Francisco.


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.